Cases of Covid-19 surging in a big way through the US as shown in most recent numbers. With emergency use FDA approval in the US, and sales team now throughout North America, one would think they would be getting some feelers for their product. European countries also bracing for onset of Northern Winter, and countries / labs etc using their product would have much higher demand. Not going away anytime soon.
Ann: Quarterly update and Appendix 4C, page-22
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
69.0¢ |
Change
-0.025(3.50%) |
Mkt cap ! $156.5M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 69.0¢ | 68.5¢ | $13.72K | 20.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8524 | 69.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.5¢ | 3598 | 2 |
View Market Depth
| Last trade - 15.44pm 15/11/2024 (20 minute delay) ? |
| GSS (ASX) Chart |